Corbus Pharmaceuticals Holdings Inc
Change company Symbol lookup
Select an option...
CRBP Corbus Pharmaceuticals Holdings Inc
DIS Walt Disney Co
WMT WALMART STORES INC
V Visa Inc
UTX United Technologies Corp
UNH UnitedHealth Group Inc
TRV Travelers Companies Inc
PG Procter & Gamble Co
PFE Pfizer Inc
NKE Nike Inc
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and halt fibrotic processes. Lenabasum stimulates the production of Specialized Pro-Resolving Lipid Mediators (SPMs) that act to resolve inflammation, and halt fibrosis by activating endogenous pathways. The Company is developing lenabasum to treat four diseases: systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis and systemic lupus erythematosus (SLE).

Closing Price
$5.69
Day's Change
0.22 (4.02%)
Bid
--
Ask
--
B/A Size
--
Day's High
5.73
Day's Low
5.43
Volume
(Light)
Volume:
739,616

10-day average volume:
948,268
739,616
  • Prev Close
    5.47
  • Today's Open
    5.50
  • Day's Range
    5.43-5.73
  • Avg Vol (10-day)
    948.3K
  • Last (time)
    3:59p ET 08/16/19
  • Last (size)
    2
  • 52-Wk Range
    4.70 - 9.11
    LowHigh
  • (08/16/18 - 02/15/19)
    21.06%
  • 76.9%
  • Market Cap
    367.9M
  • Shares Outstanding
    64.7M
  • -0.95
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.8
  • 50.68
  • (% of float 07/31/19)
    26.53

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.